Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novocure Ltd Ord Sh (NVCR)

Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,327,858
  • Shares Outstanding, K 107,606
  • Annual Sales, $ 509,340 K
  • Annual Income, $ -207,040 K
  • 60-Month Beta 0.42
  • Price/Sales 2.55
  • Price/Cash Flow N/A
  • Price/Book 3.49
Trade NVCR with:

Options Overview Details

View History
  • Implied Volatility 73.78% ( +1.82%)
  • Historical Volatility 60.45%
  • IV Percentile 38%
  • IV Rank 27.31%
  • IV High 146.55% on 08/18/23
  • IV Low 46.44% on 09/14/23
  • Put/Call Vol Ratio 0.12
  • Today's Volume 320
  • Volume Avg (30-Day) 2,480
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 25,012
  • Open Int (30-Day) 43,454

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.43
  • Number of Estimates 5
  • High Estimate -0.36
  • Low Estimate -0.52
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +14.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.70 +5.47%
on 04/23/24
16.05 -23.12%
on 03/28/24
-0.87 (-6.59%)
since 03/22/24
3-Month
11.70 +5.47%
on 04/23/24
18.04 -31.60%
on 03/08/24
-1.66 (-11.89%)
since 01/24/24
52-Week
10.87 +13.52%
on 11/13/23
83.60 -85.24%
on 05/16/23
-50.81 (-80.46%)
since 04/24/23

Most Recent Stories

More News
Why NovoCure Stock Soared 18.3% This Week

Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.

NVCR : 12.34 (+2.36%)
Why Novocure Stock Is Jumping Today

Novocure had good news mixed with some not-so-good news.

NVCR : 12.34 (+2.36%)
Stocks Settle Higher on Lower Bond Yields and Quarter-End Window Dressing

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. Stock indexes...

$SPX : 5,071.63 (+0.02%)
SPY : 505.41 (-0.05%)
$DOWI : 38,460.92 (-0.11%)
DIA : 384.44 (-0.15%)
$IUXX : 17,526.80 (+0.32%)
QQQ : 426.51 (+0.34%)
ZNM24 : 107-225 (-0.03%)
CTAS : 664.13 (-0.33%)
MRK : 127.00 (+0.09%)
MRVL : 64.85 (+1.55%)
EXR : 134.64 (+1.02%)
MDT : 80.38 (-1.12%)
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024

Stocks that traded heavily or had substantial price changes on Wednesday: Merck, Cintas rise; GameStop, MiMedx fall

NVCR : 12.34 (+2.36%)
NCNO : 30.17 (+0.03%)
JNJ : 148.53 (-0.69%)
MRK : 127.00 (+0.09%)
GME : 10.93 (+7.58%)
CTAS : 664.13 (-0.33%)
MKKGY : 32.4400 (-1.40%)
Tech Stocks Pressured by Nvidia

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.09%. Stock indexes this morning...

$SPX : 5,071.63 (+0.02%)
SPY : 505.41 (-0.05%)
$DOWI : 38,460.92 (-0.11%)
DIA : 384.44 (-0.15%)
$IUXX : 17,526.80 (+0.32%)
QQQ : 426.51 (+0.34%)
ZNM24 : 107-225 (-0.03%)
CTAS : 664.13 (-0.33%)
MRK : 127.00 (+0.09%)
MRVL : 64.85 (+1.55%)
EXR : 134.64 (+1.02%)
MDT : 80.38 (-1.12%)
Stocks Push Higher as T-note Yields Slip

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.78%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. Stock indexes this morning...

$SPX : 5,071.63 (+0.02%)
SPY : 505.41 (-0.05%)
$DOWI : 38,460.92 (-0.11%)
DIA : 384.44 (-0.15%)
$IUXX : 17,526.80 (+0.32%)
QQQ : 426.51 (+0.34%)
ZNM24 : 107-225 (-0.03%)
CTAS : 664.13 (-0.33%)
MRK : 127.00 (+0.09%)
MRVL : 64.85 (+1.55%)
MDT : 80.38 (-1.12%)
NCNO : 30.17 (+0.03%)
NovoCure (NVCR) Q4 2023 Earnings Call Transcript

NVCR earnings call for the period ending December 31, 2023.

NVCR : 12.34 (+2.36%)
NovoCure: Q4 Earnings Snapshot

NovoCure: Q4 Earnings Snapshot

NVCR : 12.34 (+2.36%)
Is Novocure Stock a Buy?

The stock isn't far from its 52-week low.

NVCR : 12.34 (+2.36%)
Why Novocure Stock Was Sick Today

Investors weren't particularly pleased with the company's third-quarter performance.

NVCR : 12.34 (+2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

See More

Key Turning Points

3rd Resistance Point 12.85
2nd Resistance Point 12.62
1st Resistance Point 12.48
Last Price 12.34
1st Support Level 12.11
2nd Support Level 11.88
3rd Support Level 11.74

See More

52-Week High 83.60
Fibonacci 61.8% 55.82
Fibonacci 50% 47.24
Fibonacci 38.2% 38.65
Last Price 12.34
52-Week Low 10.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar